0,796  0,012  Caspase 9 stimulant
0,785  0,007  15-Lipoxygenase inhibitor
0,768  0,003  Skin whitener
0,737  0,006  Aldehyde oxidase inhibitor
0,729  0,005  Cardioprotectant
0,714  0,003  Melanin inhibitor
0,709  0,007  12-Lipoxygenase inhibitor
0,707  0,006  NOS2 expression inhibitor
0,695  0,004  Monophenol monooxygenase inhibitor
0,685  0,005  Lipoxygenase inhibitor
0,683  0,023  Antineoplastic (breast cancer)
0,662  0,005  Antimutagenic
0,665  0,022  Antineoplastic (lung cancer)
0,626  0,012  Chemopreventive
0,620  0,010  Antioxidant
0,609  0,007  CYP1A2 inhibitor
0,599  0,009  Ulceration
0,592  0,012  UGT1A9 substrate
0,587  0,012  NOS3 expression inhibitor
0,609  0,047  Apoptosis agonist
0,570  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,574  0,019  Antihypercholesterolemic
0,575  0,034  Transcription factor NF kappa B inhibitor
0,563  0,022  Prostate cancer treatment
0,545  0,012  Free radical scavenger
0,546  0,019  CYP1A2 substrate
0,526  0,019  CTGF expression inhibitor
0,518  0,018  AR expression inhibitor
0,528  0,040  TNF expression inhibitor
0,497  0,010  Peroxidase inhibitor
0,484  0,004  Cystathionine beta-synthase inhibitor
0,509  0,030  5 Hydroxytryptamine release inhibitor
0,497  0,021  Caspase 3 stimulant
0,499  0,029  Histamine release inhibitor
0,472  0,003  Postmenopausal disorders treatment
0,492  0,023  Antineoplastic (cervical cancer)
0,471  0,014  Antihypertriglyceridemic
0,463  0,009  UGT1A3 substrate
0,477  0,032  GABA C receptor rho-3 antagonist
0,458  0,016  UGT1A6 substrate
0,445  0,006  UGT2B15 substrate
0,456  0,019  UGT2B4 substrate
0,439  0,004  Heat shock protein 90 antagonist
0,449  0,016  Vasodilator
0,475  0,044  Antileukemic
0,461  0,036  CYP2C19 inhibitor
0,449  0,028  Antineoplastic (glioma)
0,505  0,085  Antiinflammatory
0,447  0,031  Antineoplastic (melanoma)
0,423  0,010  Genotoxic
0,416  0,009  Topoisomerase II inhibitor
0,448  0,044  Antineoplastic (colorectal cancer)
0,443  0,038  Bone diseases treatment
0,431  0,031  Antiosteoporotic
0,431  0,032  Radioprotector
0,440  0,042  Antineoplastic (colon cancer)
0,410  0,016  UGT1A1 substrate
0,390  0,003  MAP kinase kinase 4 inhibitor
0,375  0,004  Electron transport complex I inhibitor
0,376  0,007  CYP2B6 inhibitor
0,392  0,026  Nitric oxide antagonist
0,395  0,030  Proliferative diseases treatment
0,398  0,034  Cytostatic
0,402  0,040  CYP2C19 substrate
0,403  0,043  Hepatic disorders treatment
0,380  0,025  Pyruvate kinase inhibitor
0,371  0,024  UDP-glucuronosyltransferase substrate
0,348  0,004  Gastritis treatment
0,375  0,032  Antineoplastic (glioblastoma multiforme)
0,441  0,099  Alpha-glucosidase inhibitor
0,370  0,038  Sensitization
0,361  0,029  Antineoplastic (small cell lung cancer)
0,395  0,064  CYP2C9 substrate
0,348  0,018  Antihypotensive
0,338  0,009  Antineoplastic (bone cancer)
0,334  0,005  Topoisomerase II alpha inhibitor
0,376  0,050  Antineoplastic (ovarian cancer)
0,391  0,070  Antipruritic, allergic
0,372  0,052  ICAM1 expression inhibitor
0,333  0,014  Protein-tyrosine phosphatase inhibitor
0,323  0,005  Estrogen agonist
0,356  0,043  Chemoprotective
0,331  0,017  Antineoplastic (squamous cell carcinoma)
0,328  0,016  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,322  0,011  Heat shock protein 90 alpha antagonist
0,337  0,028  GST M1-1 substrate
0,326  0,019  VCAM1 expression inhibitor
0,311  0,005  Estrogen antagonist
0,346  0,041  Antipyretic
0,313  0,009  Nitric-oxide synthase stimulant
0,356  0,054  Respiratory analeptic
0,327  0,026  UGT1A4 substrate
0,305  0,005  Estrogen receptor beta antagonist
0,307  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,336  0,040  Superoxide dismutase inhibitor
0,341  0,045  Antineoplastic (non-small cell lung cancer)
0,333  0,042  Hypoglycemic
0,331  0,043  Antiamyloidogenic
0,332  0,046  DNA damaging
0,312  0,026  Hepatoprotectant
0,316  0,035  Antineoplastic (sarcoma)
0,322  0,045  Cardiovascular analeptic
0,315  0,039  Antiparasitic
0,337  0,062  Vasodilator, coronary
0,322  0,048  Antiprotozoal (Leishmania)
0,286  0,014  NADPH oxidase inhibitor
0,277  0,005  Aromatase inhibitor
0,293  0,021  MAO inhibitor
0,287  0,020  NOS3 expression enhancer
0,279  0,014  Succinate dehydrogenase inhibitor
0,268  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,318  0,058  Antineoplastic (osteosarcoma)
0,355  0,099  Antibacterial
0,320  0,066  Antineoplastic (brain cancer)
0,258  0,005  Keratolytic
0,296  0,046  Amyloid beta aggregation inhibitor
0,271  0,023  Tubulin antagonist
0,281  0,033  P-glycoprotein inhibitor
0,271  0,023  Amylase inhibitor
0,259  0,015  Topoisomerase I inhibitor
0,328  0,087  CYP3A4 substrate
0,293  0,055  Antineoplastic (renal cancer)
0,266  0,033  Pneumotoxic
0,304  0,073  Analeptic
0,247  0,016  SULT1A3 substrate
0,245  0,016  VEGF expression inhibitor
0,249  0,021  MAO A inhibitor
0,310  0,082  Calcium channel activator
0,261  0,037  UGT2B7 substrate
0,263  0,040  Antihelmintic
0,303  0,080  CYP2D6 substrate
0,234  0,015  Antihemorrhagic
0,228  0,010  Beta glucuronidase inhibitor
0,236  0,018  5-Lipoxygenase inhibitor
0,240  0,023  Acetylcholinesterase inhibitor
0,318  0,103  CYP2C9 inhibitor
0,239  0,027  LDLR expression enhancer
0,229  0,019  MAO B inhibitor
0,293  0,084  Antifungal
0,229  0,022  Aldehyde dehydrogenase inhibitor
0,239  0,033  Antineoplastic (carcinoma)
0,219  0,013  CF transmembrane conductance regulator agonist
0,224  0,019  GABA C receptor rho-2 antagonist
0,211  0,008  Antineoplastic (uterine cancer)
0,222  0,022  Glutathione S-transferase substrate
0,300  0,102  Prostaglandin dehydrogenase inhibitor
0,215  0,016  Carbonic anhydrase XV inhibitor
0,229  0,032  Lipid peroxidase inhibitor
0,201  0,008  Estrogen receptor alpha antagonist
0,208  0,017  SULT1A1 substrate
0,232  0,041  Prostatic (benign) hyperplasia treatment
0,285  0,093  Sodium/bile acid cotransporter inhibitor
0,260  0,071  5 Hydroxytryptamine uptake stimulant
0,223  0,034  Interferon gamma antagonist
0,253  0,065  Tyrosine 3 hydroxylase inhibitor
0,193  0,007  SULT1E1 substrate
0,300  0,115  Immunosuppressant
0,266  0,082  5 Hydroxytryptamine release stimulant
0,236  0,052  Abortion inducer
0,198  0,016  Antihelmintic (Trematoda)
0,241  0,064  Cytotoxic
0,189  0,012  Creatine kinase inhibitor
0,208  0,032  UGT2B10 substrate
0,207  0,031  Antirickettsial
0,222  0,047  Antipruritic, non-allergic
0,208  0,035  UGT2B9 substrate
0,188  0,018  Carbonic anhydrase III inhibitor
0,202  0,034  Carcinogenic, group 1
0,234  0,066  Antimitotic
0,176  0,010  Macrophage migration inhibitory factor inhibitor
0,198  0,032  Antifungal enhancer
0,201  0,036  Phobic disorders treatment
0,172  0,007  Ornithine decarboxylase inhibitor
0,164  0,004  Heat shock protein 90 beta antagonist
0,219  0,060  Neurotrophic factor enhancer
0,190  0,032  Psychosexual dysfunction treatment
0,268  0,111  Apoptosis antagonist
0,199  0,042  Protein kinase stimulant
0,163  0,006  Estrogen receptor beta agonist
0,238  0,082  Antidiabetic symptomatic
0,231  0,076  Cardiodepressant
0,246  0,093  Spasmolytic
0,177  0,025  Xanthine oxidase inhibitor
0,305  0,153  Calcium channel L-type activator
0,215  0,064  Platelet adhesion inhibitor
0,169  0,018  Chronic obstructive bronchitis treatment
0,249  0,100  Antihypoxic
0,221  0,072  RNA-directed DNA polymerase inhibitor
0,196  0,048  Cholinergic
0,169  0,022  UGT2B1 substrate
0,209  0,064  Non-steroidal antiinflammatory agent
0,228  0,086  Antineoplastic (liver cancer)
0,161  0,020  Breast cancer-resistant protein inhibitor
0,157  0,018  DOPA decarboxylase inhibitor
0,240  0,104  Antineoplastic (multiple myeloma)
0,145  0,010  Alpha tubulin antagonist
0,168  0,037  Cholesterol synthesis inhibitor
0,167  0,037  Farnesoid X receptor antagonist
0,165  0,038  Interleukin 4 antagonist
0,161  0,033  Beta amyloid protein antagonist
0,228  0,101  Antineoplastic (bladder cancer)
0,238  0,111  Streptokinase A inhibitor
0,154  0,028  DNA repair enzyme inhibitor
0,196  0,071  Carcinogenic
0,152  0,027  Antiviral (Influenza B)
0,152  0,030  Photosensitizer
0,227  0,104  Transcription factor STAT3 inhibitor
0,148  0,026  Multidrug resistance-associated protein 1 inhibitor
0,140  0,020  UGT2B11 substrate
0,147  0,029  Sulfotransferase substrate
0,165  0,047  Antiseptic
0,168  0,051  Antiprotozoal (Coccidial)
0,225  0,109  Antineoplastic (pancreatic cancer)
0,129  0,015  Beta tubulin antagonist
0,205  0,092  Angiogenesis stimulant
0,124  0,011  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,141  0,028  Urease inhibitor
0,152  0,041  Heat shock protein 70 antagonist
0,198  0,087  Antineoplastic enhancer
0,140  0,030  Antifungal (Pneumocystis)
0,244  0,134  FMO1 substrate
0,208  0,098  Aryl hydrocarbon receptor agonist
0,134  0,025  Carbonic anhydrase XIII inhibitor
0,135  0,027  Androgen antagonist
0,126  0,018  HIV-1 integrase (3'-Processing) inhibitor
0,132  0,025  Carbonic anhydrase VI inhibitor
0,110  0,006  Glutamate (mGluR7) antagonist
0,195  0,097  Cyclic AMP phosphodiesterase inhibitor
0,154  0,057  Alkaline phosphatase inhibitor
0,141  0,044  Papain-like protease (SARS coronavirus) inhibitor
0,146  0,052  Cyclooxygenase 3 inhibitor
0,133  0,043  Choleretic
0,116  0,027  Histidine decarboxylase inhibitor
0,227  0,139  CYP3A4 inhibitor
0,166  0,079  Mutagenic
0,130  0,043  Alpha 2c adrenoreceptor antagonist
0,107  0,022  D-Ala-D-Ala ligase inhibitor
0,122  0,037  Prolactin inhibitor
0,161  0,076  Arachidonic acid antagonist
0,096  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,119  0,035  Carcinogenic, group 2A
0,136  0,053  Coagulant
0,097  0,015  Protease activated receptor antagonist
0,139  0,058  M18 aspartyl aminopeptidase inhibitor
0,140  0,063  Cyclooxygenase 1 inhibitor
0,206  0,129  Transcription factor STAT inhibitor
0,124  0,047  HDL-cholesterol increasing
0,122  0,046  Mediator release inhibitor
0,125  0,050  Mucolytic
0,148  0,074  Acaricide
0,111  0,037  Actinic keratosis treatment
0,143  0,070  Mannose-6-phosphate isomerase inhibitor
0,220  0,148  Cholesterol antagonist
0,178  0,106  Teratogen
0,100  0,028  Histone deacetylase SIRT1 stimulant
0,100  0,028  Histone deacetylase stimulant
0,205  0,133  Radiosensitizer
0,103  0,032  Telomerase inhibitor
0,090  0,020  Aldose reductase inhibitor
0,125  0,055  Microtubule formation inhibitor
0,211  0,141  Insulysin inhibitor
0,097  0,027  SULT1A2 substrate
0,181  0,112  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,110  0,042  Antineoplastic antibiotic
0,105  0,039  Bile acid receptor antagonist
0,119  0,053  GABA C receptor antagonist
0,069  0,004  Estrogen-related receptor beta antagonist
0,081  0,016  Transcription factor RelA inhibitor
0,112  0,047  Anabolic
0,091  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,131  0,067  Toll-Like receptor 2 antagonist
0,096  0,033  Thioredoxin reductase inhibitor
0,146  0,083  Aldose reductase substrate
0,077  0,015  Postcoital contraceptive
0,084  0,024  5 Hydroxytryptamine 2A agonist
0,073  0,013  Estrogen receptor alpha agonist
0,178  0,118  Antineoplastic (lymphocytic leukemia)
0,124  0,064  Alkylator
0,176  0,117  Antineoplastic (lymphoma)
0,073  0,014  Potassium channel Kv1.3 blocker
0,182  0,124  Tumour necrosis factor alpha release inhibitor
0,138  0,081  Ca2+-transporting ATPase inhibitor
0,222  0,164  GST A substrate
0,108  0,051  Sphingomyelinase inhibitor
0,092  0,035  Dopamine D2 antagonist
0,139  0,083  Antidote
0,114  0,058  Carcinogenic, group 2B
0,115  0,059  Chelator
0,165  0,109  Embryotoxic
0,079  0,025  Xanthine dehydrogenase inhibitor
0,092  0,039  Na+ K+ transporting ATPase inhibitor
0,083  0,030  Leukotriene antagonist
0,091  0,039  Estrogen-related receptor beta agonist
0,102  0,051  Uric acid excretion stimulant
0,092  0,042  Dopamine antagonist
0,085  0,035  HIV-1 integrase inhibitor
0,104  0,057  GABA C receptor rho-1 antagonist
0,067  0,021  Leukotriene B4 antagonist
0,134  0,088  Antiviral (Influenza A)
0,188  0,142  DNA synthesis inhibitor
0,104  0,059  Butyrylcholinesterase inhibitor
0,083  0,040  Lipase inhibitor
0,136  0,092  Eye irritation, high
0,105  0,063  Expectorant
0,134  0,093  Antidiarrheal
0,169  0,129  Antiviral (Ebola)
0,130  0,090  Antiischemic, cerebral
0,106  0,067  DNA intercalator
0,053  0,015  DNA gyrase subunit A inhibitor
0,106  0,068  Skin irritative effect
0,115  0,078  Contraceptive female
0,111  0,075  DNA polymerase I inhibitor
0,093  0,057  Thioredoxin inhibitor
0,140  0,106  Dual specificity phosphatase inhibitor
0,120  0,087  Vanilloid 1 agonist
0,131  0,097  Antifungal (Cryptococcus)
0,103  0,072  Alpha 2b adrenoreceptor antagonist
0,092  0,063  Antiviral (Rhinovirus)
0,069  0,040  Aryl hydrocarbon receptor antagonist
0,041  0,013  Nucleoside transporters inhibitor
0,140  0,113  Amyloid beta precursor protein antagonist
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,064  0,038  Antidote, heavy metal
0,058  0,032  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,092  0,066  Alpha 2d adrenoreceptor antagonist
0,055  0,030  Glucose-6-phosphate translocase inhibitor
0,034  0,010  Sodium/glucose cotransporter 2 inhibitor
0,245  0,221  Alzheimer's disease treatment
0,052  0,029  Topoisomerase II beta inhibitor
0,141  0,119  Antineoplastic (gastric cancer)
0,075  0,055  Antitreponemal
0,057  0,038  Leukotriene C antagonist
0,132  0,114  Prostate disorders treatment
0,036  0,018  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,030  0,013  Dopamine autoreceptor agonist
0,118  0,101  Cyclooxygenase inhibitor
0,058  0,042  Ryanodine receptor antagonist
0,044  0,028  GABA B receptor antagonist
0,081  0,065  Myeloperoxidase inhibitor
0,168  0,153  Lipoprotein disorders treatment
0,083  0,067  Granulocyte macrophage colony stimulating factor agonist
0,056  0,041  Fatty acid synthase inhibitor
0,124  0,110  Phospholipase A2 inhibitor
0,059  0,045  Neuraminidase inhibitor
0,042  0,027  DNA-dependent protein kinase inhibitor
0,028  0,014  Sodium/glucose cotransporter inhibitor
0,041  0,027  Cholesterol absorption inhibitor
0,071  0,057  Alpha 2a adrenoreceptor antagonist
0,067  0,053  SULT2A1 substrate
0,045  0,033  Carbonic anhydrase VII inhibitor
0,125  0,113  Adenylate cyclase stimulant
0,140  0,128  Phospholipase C inhibitor
0,086  0,074  Protein kinase C zeta inhibitor
0,112  0,101  Antianorexic
0,161  0,150  Myocardial infarction treatment
0,033  0,022  Estrogen-related receptor alpha antagonist
0,128  0,118  Dual specificity phosphatase 3 inhibitor
0,085  0,075  Glutamate release inhibitor
0,108  0,098  Bone formation stimulant
0,060  0,050  Dopamine D1 antagonist
0,016  0,008  Antibiotic Tetracycline-like
0,140  0,132  Catenin beta inhibitor
0,043  0,036  Adenylate cyclase 1 inhibitor
0,092  0,086  Endometrios treatment
0,022  0,016  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,076  0,071  Antiprotozoal activity enhancer
0,061  0,057  Peroxisome proliferator-activated receptor gamma agonist
0,086  0,082  Interleukin 12 antagonist
0,023  0,019  Sodium/glucose cotransporter 1 inhibitor
0,066  0,063  Glycine receptor agonist
0,056  0,054  Antimycoplasmal
0,097  0,094  TRPA1 agonist
0,073  0,071  Antispirochetal
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,020  0,018  Leukotriene B4 receptor 2 antagonist
0,107  0,105  Antibacterial (Helicobacter pylori)
0,074  0,074  Alpha 2 adrenoreceptor antagonist
0,133  0,133  Psychostimulant

